SCHEMBL23536734

SCHEMBL23536734

N#Cc1cc(F)cc(CCN)c1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.46
MAOB P27338 4/20 0.38
LOXL2 Q9Y4K0 1/20 0.36
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319482 0.84 LOXL2 (0.48) MAOBLOXL2
SCHEMBL30335660 0.84 LOXL2 (0.48) MAOBLOXL2
SCHEMBL27868543 0.81 GRM5 (0.33)
SCHEMBL1014548 0.79 TAAR1 (0.60) TAAR1MAOBLOXL2
SCHEMBL20646934 0.78 TSHR (0.44)
SCHEMBL23536729 0.77 TAAR1 (0.46) TAAR1LOXL2ADRA2C
SCHEMBL16955446 0.77 PGR (0.35)
SCHEMBL1469433 0.77 TAAR1 (0.46) TAAR1MAOB
Hydrochloric Acid SCHEMBL2211247 0.77 TAAR1 (0.58) TAAR1MAOBLOXL2
SCHEMBL5222310 0.76 IDO1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076418-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-10-26 EP disclosed
WO-2021127429-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2021-06-24 WO disclosed